Q2 2024 |
252 |
$436M |
+$70.3M |
-$17.7M |
+$52.6M |
AAPL, NVDA, AMZN, RC, ORCL
|
13F-HR |
8/13/2024, 11:45 AM |
Q1 2024 |
236 |
$395M |
+$29.9M |
-$23.7M |
+$6.2M |
AAPL, NVDA, RC, AMZN, ORCL
|
13F-HR |
5/15/2024, 10:05 AM |
Q4 2023 |
233 |
$361M |
+$51.2M |
-$15.9M |
+$35.3M |
AAPL, RC, NVDA, AMZN, SNOW
|
13F-HR |
2/14/2024, 03:17 PM |
Q3 2023 |
223 |
$297M |
+$8.52M |
-$45.2M |
-$36.7M |
AAPL, RC, NVDA, BXSL, ORCL
|
13F-HR |
11/13/2023, 02:27 PM |
Q2 2023 |
246 |
$345M |
+$9.34M |
-$8.51M |
+$824K |
AAPL, RC, BXSL, NVDA, ORCL
|
13F-HR |
8/11/2023, 10:08 AM |
Q1 2023 |
247 |
$321M |
+$17.6M |
-$18.8M |
-$1.19M |
AAPL, RC, BXSL, ORCL, NVDA
|
13F-HR |
5/15/2023, 03:00 PM |
Q4 2022 |
244 |
$298M |
+$61.8M |
-$8.09M |
+$53.7M |
AAPL, RC, BXSL, PNC, ORCL
|
13F-HR |
2/14/2023, 12:16 PM |
Q2 2022 |
207 |
$244M |
+$33.2M |
-$9.12M |
+$24.1M |
AAPL, RC, PNC, AMZN, ORCL
|
13F-HR |
8/15/2022, 10:14 AM |
Q1 2022 |
209 |
$268M |
+$22.1M |
-$12.6M |
+$9.53M |
AAPL, AMZN, PNC, ORCL, FOCS
|
13F-HR |
5/12/2022, 11:15 AM |
Q4 2021 |
201 |
$269M |
+$20M |
-$12.9M |
+$7.06M |
AAPL, PNC, FOCS, ORCL, AMZN
|
13F-HR |
2/8/2022, 11:10 AM |
Q3 2021 |
192 |
$242M |
+$16.1M |
-$16.4M |
-$235K |
AAPL, ORCL, PNC, AMZN, FOCS
|
13F-HR |
11/12/2021, 04:49 PM |
Q2 2021 |
193 |
$247M |
+$8.22M |
-$7.76M |
+$467K |
AAPL, AMZN, ORCL, PNC, FOCS
|
13F-HR |
8/16/2021, 10:23 AM |
Q1 2021 |
192 |
$230M |
+$12.7M |
-$18.7M |
-$6.03M |
AAPL, AMZN, ORCL, PNC, FOCS
|
13F-HR |
5/17/2021, 11:05 AM |
Q4 2020 |
183 |
$224M |
+$8.97M |
-$11.8M |
-$2.82M |
AAPL, AMZN, ORCL, PNC, FOCS
|
13F-HR |
2/12/2021, 01:21 PM |
Q3 2020 |
175 |
$199M |
+$33.5M |
-$8.07M |
+$25.4M |
AAPL, AMZN, ORCL, FOCS, PNC
|
13F-HR |
11/12/2020, 04:16 PM |
Q2 2020 |
181 |
$173M |
+$41.2M |
-$9.1M |
+$32.1M |
AAPL, AMZN, ORCL, FOCS, PNC
|
13F-HR |
8/4/2020, 11:37 AM |
Q1 2020 |
147 |
$120M |
+$49.1M |
-$11.2M |
+$37.8M |
AAPL, ORCL, CME, AMZN, PNC
|
13F-HR |
5/8/2020, 03:32 PM |
Q4 2019 |
112 |
$112M |
+$7.51M |
-$8.29M |
-$781K |
CME, AAPL, ORCL, FOCS, GER
|
13F-HR |
2/13/2020, 04:35 PM |
Q3 2019 |
111 |
$109M |
+$25.6M |
-$27M |
-$1.4M |
CME, ORCL, AAPL, GER, GMZ
|
13F-HR |
11/12/2019, 10:34 AM |
Q2 2019 |
106 |
$110M |
+$4.41M |
-$5.13M |
-$721K |
CME, ORCL, AAPL, GER, GMZ
|
13F-HR |
8/13/2019, 04:37 PM |
Q1 2019 |
105 |
$109M |
+$8.64M |
-$3.93M |
+$4.7M |
ORCL, CME, GER, GMZ, AAPL
|
13F-HR |
5/14/2019, 01:35 PM |
Q4 2018 |
98 |
$93.9M |
+$11.9M |
-$13.2M |
-$1.32M |
CME, ORCL, GMZ, GER, AAPL
|
13F-HR |
2/4/2019, 06:31 PM |
Q3 2018 |
100 |
$114M |
+$5.39M |
-$2.77M |
+$2.63M |
AAPL, ORCL, CME, GER, GMZ
|
13F-HR |
11/5/2018, 10:22 AM |
Q2 2018 |
99 |
$103M |
+$26.4M |
-$2.78M |
+$23.6M |
AAPL, CME, ORCL, GER, GMZ
|
13F-HR |
8/6/2018, 02:44 PM |
Q1 2018 |
86 |
$76.5M |
+$13.8M |
-$29.6M |
-$15.8M |
CME, ORCL, GER, GMZ, EVV
|
13F-HR |
5/14/2018, 12:50 PM |
Q4 2017 |
94 |
$96.2M |
$0 |
$0 |
|
AAPL, ORCL, CME, GER, GMZ
|
13F-HR |
2/2/2018, 01:27 PM |